NU51PS005175
Cooperative Agreement
Overview
Grant Description
Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments
The Kentucky Department for Public Health (KDPH) is committed to building a robust Viral Hepatitis Program (VHP) to develop, expand, and oversee prevention and surveillance efforts for Hepatitis B and Hepatitis C. CDC-RFA-PS17-1702 and CDC-RFA-PS17-1703 afforded KDPH the opportunity to start a VHP. The program has grown substantially since 2019, and KDPH now has staff capacity better matched to the high burden of hepatitis in Kentucky.
VHP will prioritize enhanced surveillance that approximates the prevalence of Hepatitis B and Hepatitis C, examines co-infection with HIV, identifies populations most at-risk of hepatitis infection and outbreaks, and builds continuums of care for Kentuckians living with Hepatitis B and Hepatitis C. These data will be the foundation for targeting outreach and prevention efforts, augmenting provider education, improving access to linkage to care and patient navigation, and, ultimately, focusing hepatitis elimination planning.
The program will engage individuals with lived experience in ways that do not tokenize or exploit but, rather, provide insight that informs program efforts and is an enriching, productive experience for the participants. The VHP is committed to avoiding silos and working collaboratively with HIV, harm reduction, and behavioral health to approach elimination in a way that doesn't only prevent liver disease but that improves overall health and well-being for people who use drugs, people living with hepatitis, and people living with HIV.
The Kentucky Department for Public Health (KDPH) is committed to building a robust Viral Hepatitis Program (VHP) to develop, expand, and oversee prevention and surveillance efforts for Hepatitis B and Hepatitis C. CDC-RFA-PS17-1702 and CDC-RFA-PS17-1703 afforded KDPH the opportunity to start a VHP. The program has grown substantially since 2019, and KDPH now has staff capacity better matched to the high burden of hepatitis in Kentucky.
VHP will prioritize enhanced surveillance that approximates the prevalence of Hepatitis B and Hepatitis C, examines co-infection with HIV, identifies populations most at-risk of hepatitis infection and outbreaks, and builds continuums of care for Kentuckians living with Hepatitis B and Hepatitis C. These data will be the foundation for targeting outreach and prevention efforts, augmenting provider education, improving access to linkage to care and patient navigation, and, ultimately, focusing hepatitis elimination planning.
The program will engage individuals with lived experience in ways that do not tokenize or exploit but, rather, provide insight that informs program efforts and is an enriching, productive experience for the participants. The VHP is committed to avoiding silos and working collaboratively with HIV, harm reduction, and behavioral health to approach elimination in a way that doesn't only prevent liver disease but that improves overall health and well-being for people who use drugs, people living with hepatitis, and people living with HIV.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Kentucky
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 04/30/26 to 04/30/27 and the total obligations have increased 108150% from $3,336 to $3,611,216.
Kentucky Cabinet For Health & Family Services was awarded
Kentucky Hepatitis Prevention & Surveillance Grant
Cooperative Agreement NU51PS005175
worth $3,611,216
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in May 2021 with work to be completed primarily in Kentucky United States.
The grant
has a duration of 6 years and
was awarded through assistance program 93.270 Viral Hepatitis Prevention and Control.
The Cooperative Agreement was awarded through grant opportunity Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments.
Status
(Ongoing)
Last Modified 5/21/26
Period of Performance
5/1/21
Start Date
4/30/27
End Date
Funding Split
$3.6M
Federal Obligation
$0.0
Non-Federal Obligation
$3.6M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU51PS005175
Transaction History
Modifications to NU51PS005175
Additional Detail
Award ID FAIN
NU51PS005175
SAI Number
NU51PS005175-745190552
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
LECJQDCLHVE5
Awardee CAGE
1M3S5
Performance District
KY-90
Senators
Mitch McConnell
Rand Paul
Rand Paul
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Health and Human Services (075-0950) | Health care services | Grants, subsidies, and contributions (41.0) | $1,204,137 | 99% |
Modified: 5/21/26